FENC
Closed
Fennec Pharmaceuticals Inc
8.3
0.0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 8.3
Day's Range: 8.28 - 8.4837
Send
sign up or login to leave a comment!
When Written:
8.32
Fennec Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of cancer treatments. The company's lead product candidate is called PEDMARK, which is a formulation of sodium thiosulfate that is designed to reduce the incidence and severity of ototoxicity (hearing loss) associated with platinum-based chemotherapy in children. PEDMARK has been granted Breakthrough Therapy designation by the US FDA and is currently undergoing Phase III clinical trials. Fennec Pharmaceuticals Inc was founded in 1996 and is headquartered in Durham, North Carolina. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol FENC.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








